| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antigenic determinants at the carboxy terminus of chicken egg white riboflavin carrier protein (RCP): epitope mapping and antibody-mediated pregnancy curtailment in rodents
|
Koshy, Beena T.
|
|
1996
|
14 |
4 |
p. 307-312
6 p.
|
artikel
|
| 2 |
Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease
|
Sonoda, Kengo
|
|
1996
|
14 |
4 |
p. 277-284
8 p.
|
artikel
|
| 3 |
Calendar
|
|
|
1996
|
14 |
4 |
p. 358-
1 p.
|
artikel
|
| 4 |
Chimeric polypeptide containing binding and effector portions; is internalized by target cells to release biologically active peptides for use as vaccine or in adoptive immunotherapy
|
|
|
1996
|
14 |
4 |
p. 357-
1 p.
|
artikel
|
| 5 |
Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody
|
Galili, Uri
|
|
1996
|
14 |
4 |
p. 321-328
8 p.
|
artikel
|
| 6 |
Evaluation of subunit vaccines against feline immunodeficiency virus infection
|
Verschoor, Ernst J.
|
|
1996
|
14 |
4 |
p. 285-289
5 p.
|
artikel
|
| 7 |
Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals
|
Follmann, Erich H.
|
|
1996
|
14 |
4 |
p. 270-273
4 p.
|
artikel
|
| 8 |
Fusion glycoprotein from HCMV and HSV; human cytomegalo virus glycoprotein gB and herpes simplex virus glycoprotein gD fusion protein useful as a recombinant vaccine
|
|
|
1996
|
14 |
4 |
p. 357-
1 p.
|
artikel
|
| 9 |
Global DTP manufacturing capacity and capability. Status report: January 1995
|
Milstien, Julie B.
|
|
1996
|
14 |
4 |
p. 313-320
8 p.
|
artikel
|
| 10 |
HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates
|
Davis, D.
|
|
1996
|
14 |
4 |
p. 353-354
2 p.
|
artikel
|
| 11 |
Immune response to a booster dose of enhanced potency inactivated polio vaccine administered in association with HBV vaccine in adolescents
|
Pregliasco, Fabrizio
|
|
1996
|
14 |
4 |
p. 267-269
3 p.
|
artikel
|
| 12 |
Improvement of the Brucella abortus B19 vaccine by its preparation in a glycerol based medium
|
Sangari, Félix J.
|
|
1996
|
14 |
4 |
p. 274-276
3 p.
|
artikel
|
| 13 |
Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems
|
Sjölander, Sigrid
|
|
1996
|
14 |
4 |
p. 344-352
9 p.
|
artikel
|
| 14 |
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
|
Pittman, Phillip R.
|
|
1996
|
14 |
4 |
p. 337-343
7 p.
|
artikel
|
| 15 |
Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit
|
Haan, Lolke de
|
|
1996
|
14 |
4 |
p. 260-266
7 p.
|
artikel
|
| 16 |
Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone
|
Samore, Matthew H.
|
|
1996
|
14 |
4 |
p. 290-297
8 p.
|
artikel
|
| 17 |
Polynucleotide encoding modified group-B streptococcal beta-antigen; Streptococcus sp. recombinant protein which does not bind to human IgA, and production by vector expression in host cell, for application as a recombinant vaccine
|
|
|
1996
|
14 |
4 |
p. 357-
1 p.
|
artikel
|
| 18 |
Protection against oral challenge three months after i.v. immunization of BALB c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen
|
Hormaeche, Carlos E.
|
|
1996
|
14 |
4 |
p. 251-259
9 p.
|
artikel
|
| 19 |
Quantitative determination of immune response against hepatitis A virus capsids after natural infection
|
Wang, Chwan-Heng
|
|
1996
|
14 |
4 |
p. 355-356
2 p.
|
artikel
|
| 20 |
Target peptide-penl protein fusion polypeptide; fusion protein production using a vector, for application in epitope identification, T-lymphocyte activator identification and in a recombinant vaccine
|
|
|
1996
|
14 |
4 |
p. 357-
1 p.
|
artikel
|
| 21 |
Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
|
Vaughn, David W.
|
|
1996
|
14 |
4 |
p. 329-336
8 p.
|
artikel
|
| 22 |
The influence of a recombinant-HBsAg vaccine on the repertoire of transcribed T-cell receptor β chain variable region genes in peripheral blood in humans
|
Abbott, William G.H.
|
|
1996
|
14 |
4 |
p. 301-306
6 p.
|
artikel
|
| 23 |
Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins
|
Rinella Jr, Joseph V.
|
|
1996
|
14 |
4 |
p. 298-300
3 p.
|
artikel
|
| 24 |
Vaccine for treatment of candidiasis; comprises adhesins isolated from Candida albicans or monoclonal antibody specific for C. albicans phosphomannoprotein
|
|
|
1996
|
14 |
4 |
p. 357-
1 p.
|
artikel
|
Tijdschrift beschrijving